Gland Pharma shares tumble over 3% after Fosun Pharma likely sells 6.2% stake via block deal

Shares of Gland pharma fell 3.7% as Shanghai-based Fosun Pharma offloaded a 6.2% stake in a block deal managed by UBS, decreasing its holding from 75% to 58.36%.